Navigation Links
FDA Approves 4 Swine Flu Vaccines
Date:9/15/2009

inical studies of the H1N1 vaccine are continuing to determine the optimal dose in children, with the results expected shortly, the FDA said.

The four vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and Sanofi Pasteur Inc. All four firms manufacture the H1N1 vaccines using the same processes, and have a proven safety record producing seasonal influenza vaccines, according to the FDA.

The preliminary trials of the vaccine has shown it to be well-tolerated, with side effects typical of seasonal flu vaccines. Those side effects include soreness at the injection site, as well as possible mild fever, body aches, and fatigue for a few days after the inoculation. For the nasal spray vaccine, the most common side effects include runny nose or nasal congestion for all ages, sore throats in adults, and -- in children 2 to 6 years old -- fever, the FDA said.

The FDA stressed that the H1N1 vaccine won't protect against regular seasonal flu. That's why people are urged to get their seasonal flu shots now, even though the H1N1 virus accounts for about 98 percent of the flu circulating right now in the United States.

"We think the novel strain of H1N1 is going to be widely circulating, but as the season progresses we may see other seasonal flu viruses emerge and start to spread. So it makes sense that people get their seasonal flu shot, because we could very well see those strains of influenza circulate widely as our season progresses," said Tom Skinner, a spokesman for the U.S. Centers for Disease Control and Prevention.

On Monday, several news studies suggested that people infected with swine flu seem to be contagious longer than patients with ordinary seasonal flu.

But it's not clear what impact the findings will have on health-care experts' recommendations to combat the H1N1 swine flu, since the virus continues to produce relatively mild infections in most people and reco
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
2. FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
3. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
4. First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Programs Viability
5. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
6. FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)
7. FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
8. FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
9. House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services
10. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
11. FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 4 Swine Flu Vaccines 
(Date:4/21/2015)... Meadows, Ill. (PRWEB) April 21, 2015 ... to the late cosmetic dermatologist Fredric S. Brandt, M.D., ... , Dr. Brandt, an ASDS member since 1982, died ... home. The funds are designed to provide opportunities for ... the field of cosmetic dermatology that Dr. Brandt held ...
(Date:4/21/2015)... BAR, CALIF. (PRWEB) April 21, 2015 ... leading provider of enterprise Time and Attendance / ... 33rd Annual Congress from the American Payroll Association ... Partner Conference. , The APA has been the ... Congress brings workshops, networking opportunities, and recertification credits. ...
(Date:4/21/2015)... The PracticeMatch Career Fair will take ... at the William and Ida Friday Center at UNC-Chapel Hill, ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says “Chapel Hill is an ideal location to hold ...
(Date:4/21/2015)... DC (PRWEB) April 21, 2015 ... announce the launch of Medicare-Medicaid Dual Eligibles Database, ... focuses on care provided to the more than ... who account for more than $300 billion in ... researchers – the same team that also creates ...
(Date:4/21/2015)... eSight is the only technology in the world that ... Tuesday, May 5th, Low Vision Specialists of Maryland and ... an unveiling and demonstration of the technology at 8:30 a.m ... will be the first ophthalmic practice in Maryland to offer ... will be available on the day of the unveiling. , ...
Breaking Medicine News(10 mins):Health News:ASDS honors the legacy of Dr. Fredric Brandt 2Health News:ASDS honors the legacy of Dr. Fredric Brandt 3Health News:ASDS honors the legacy of Dr. Fredric Brandt 4Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 2Health News:NOVAtime Participates in 2015 APA Congress and NetSuite SuiteWorld Conferences in May 3Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 2Health News:eSight Electronic Glasses That Enable The Legally Blind To See – First In The World – Coming To Maryland 3
... earliest intervention may reduce risk , , MONDAY, March 30 (HealthDay ... six months of life may be more prone to obesity ... our preventive methods when children are much younger," said study ... of weeks of life, we can start guiding parents about ...
... Billion Each Year According to the Better Sleep CouncilDALLAS, March ... Unfortunately, sleep is usually one of the first things people ... In a turbulent economy, nearly 30 percent of Americans ... according to a 2009 Sleep in America poll by the ...
... preference for procedures that offer improved aesthetic results will ... to Millennium Research GroupWALTHAM, Mass., March 30 According ... Markets for Dental Implants 2009 report, although ... growth in the short term, the US dental implant ...
... Enhancements maximize and automate physician practice reporting, collections and ... March 30 iMedica Corporation ... for physician practices, today announced the availability of its ... 2009 is the latest version of iMedica,s award-winning Electronic ...
... NUVA ), a medical device company focused ... the spine, announced today that due to the successful ... the transfer of the processing of Osteocel Plus from ... own exclusive supply chain. Since the May 2008 announcement ...
... Two-Year Study- Conference Call Scheduled for Today at ... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... (Behavioral modification and Lorcaserin for Overweight and Obesity ... the safety and efficacy of lorcaserin for weight ...
Cached Medicine News:Health News:Rapid Infant Weight Gain Linked to Childhood Obesity 2Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 2Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 3Health News:Dental Implant Market to Exceed $1 Billion by 2013 Despite Current Economic Slowdown 2Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 2Health News:iMedica Corporation Announces the Release of Patient Relationship Manager 2009 3Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 2Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 3Health News:Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility 4Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 2Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 3Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 4Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 5Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 6Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 7Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 8Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 9Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 10Health News:Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints 11
(Date:4/21/2015)... LOS ANGELES , April 21, 2015 /PRNewswire/ ... quality plan administrator and the exclusive worldwide sales, ... GenStrip™ 50, the FDA-cleared Green Alternative Strip, specifically ... & Johnson,s LifeScan OneTouch Ultra family of glucose ... diabetic use, announced today that Johnson & Johnson/Lifescan ...
(Date:4/21/2015)... , April 21, 2015  The American Association ... Food and Drug Administration that the agency,s regulatory ... the last 25 years to protect the public ... medicines. AAHP, the industry,s trade association, was joined ... homeopathic medicines to engage in productive discussions with ...
(Date:4/21/2015)... , April 21, 2015  Edico Genome today ... solutions with Intel,s Xeon processors to accelerate next ... will enable completion of primary and secondary NGS ... decreasing costs, streamlining data analysis in the cloud ... of big data sets, such as analysis of ...
Breaking Medicine Technology:Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 2Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case 3Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 2Edico Genome Collaborates with Intel to Overcome Big Data Bottleneck in Next-Generation Sequencing 3
... Also Announces Deal for Vaccine Delivery System, ... Corporation announced today that the Company's HIV ... primate model.,Mucosal IgA antibodies are considered a ... HIV. The data were presented by,Sylvain Fleury, ...
... Patients Prefer Orapred ODT Over Liquid, ALPHARETTA, ... announced today survey results showing that,children prefer ... over liquid steroids.(1) , The results of ... children (n=973), showed that 89% (n=870) of ...
Cached Medicine Technology:Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 2Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 4Orapred ODT Tastes Good 2Orapred ODT Tastes Good 3
LigaSure system generator, bipolar only. Designed to permanently seal vessels and tissue bundles....
Sabre 180 is a powerful niche generator....
Sabre 180 is a powerful niche generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: